Convertible Loan Notes

By

Regulatory News | 03 Jul, 2024

Updated : 07:01

RNS Number : 8841U
Insig AI Plc
03 July 2024
 

3 July 2024

Insig AI plc

("Insig AI" or the "Company")

 

Convertible Loan Notes

 

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce the redemption dates of the Company's existing convertible loan notes ("CLN") of £1,000,000 and £500,000 issued to Richard Bernstein and David Kyte respectively, have been extended to 30 September 2025.

 

In addition, the Company has agreed with Richard Bernstein that the interest due of 8 per cent. per annum on the CLN issued to him be reduced to 6.0% per annum, effective 1 July 2024. The interest rate of 12.0% per annum on the CLN issued to David Kyte remains unchanged.

 

The revised terms of the CLN issued to Richard Bernstein, due to him being a director of the Company, is deemed to be a related party transaction pursuant to AIM Rule 13. The directors of the Company (excluding Richard Bernstein), having consulted with Zeus Capital Limited, the Company's nominated adviser, consider that the revised terms of the CLN issued to Richard Bernstein are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

 

For further information, please visit www.insg.ai or contact:

 

Insig AI plc                                                                                        richard.bernstein@insg.ai

Richard Bernstein (CEO)          

  

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold                                                         +44 (0)20 3829 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFLIDDIFIIS

Last news